PMC:7172841 / 441-685
Annnotations
LitCovid-PD-FMA-UBERON
{"project":"LitCovid-PD-FMA-UBERON","denotations":[{"id":"T1","span":{"begin":39,"end":49},"obj":"Body_part"},{"id":"T2","span":{"begin":94,"end":103},"obj":"Body_part"},{"id":"T3","span":{"begin":123,"end":126},"obj":"Body_part"},{"id":"T4","span":{"begin":183,"end":194},"obj":"Body_part"},{"id":"T5","span":{"begin":201,"end":212},"obj":"Body_part"},{"id":"T6","span":{"begin":238,"end":243},"obj":"Body_part"}],"attributes":[{"id":"A1","pred":"fma_id","subj":"T1","obj":"http://purl.org/sig/ont/fma/fma63261"},{"id":"A2","pred":"fma_id","subj":"T2","obj":"http://purl.org/sig/ont/fma/fma62852"},{"id":"A3","pred":"fma_id","subj":"T3","obj":"http://purl.org/sig/ont/fma/fma84795"},{"id":"A4","pred":"fma_id","subj":"T4","obj":"http://purl.org/sig/ont/fma/fma62863"},{"id":"A5","pred":"fma_id","subj":"T5","obj":"http://purl.org/sig/ont/fma/fma62863"},{"id":"A6","pred":"fma_id","subj":"T6","obj":"http://purl.org/sig/ont/fma/fma68646"}],"text":"All patients with SRF displayed either macrophage activation syndrome (MAS) or very low human leukocyte antigen D related (HLA-DR) expression accompanied by profound depletion of CD4 lymphocytes, CD19 lymphocytes, and natural killer (NK) cells."}
LitCovid-PD-MONDO
{"project":"LitCovid-PD-MONDO","denotations":[{"id":"T8","span":{"begin":39,"end":69},"obj":"Disease"},{"id":"T9","span":{"begin":71,"end":74},"obj":"Disease"}],"attributes":[{"id":"A8","pred":"mondo_id","subj":"T8","obj":"http://purl.obolibrary.org/obo/MONDO_0015545"},{"id":"A9","pred":"mondo_id","subj":"T9","obj":"http://purl.obolibrary.org/obo/MONDO_0015545"}],"text":"All patients with SRF displayed either macrophage activation syndrome (MAS) or very low human leukocyte antigen D related (HLA-DR) expression accompanied by profound depletion of CD4 lymphocytes, CD19 lymphocytes, and natural killer (NK) cells."}
LitCovid-PD-CLO
{"project":"LitCovid-PD-CLO","denotations":[{"id":"T2","span":{"begin":50,"end":60},"obj":"http://purl.obolibrary.org/obo/CLO_0001658"},{"id":"T3","span":{"begin":88,"end":93},"obj":"http://purl.obolibrary.org/obo/NCBITaxon_9606"},{"id":"T4","span":{"begin":179,"end":182},"obj":"http://purl.obolibrary.org/obo/PR_000001004"},{"id":"T5","span":{"begin":196,"end":200},"obj":"http://purl.obolibrary.org/obo/CLO_0053432"},{"id":"T6","span":{"begin":233,"end":243},"obj":"http://purl.obolibrary.org/obo/CL_0000623"}],"text":"All patients with SRF displayed either macrophage activation syndrome (MAS) or very low human leukocyte antigen D related (HLA-DR) expression accompanied by profound depletion of CD4 lymphocytes, CD19 lymphocytes, and natural killer (NK) cells."}
LitCovid-PD-CHEBI
{"project":"LitCovid-PD-CHEBI","denotations":[{"id":"T1","span":{"begin":104,"end":111},"obj":"Chemical"},{"id":"T2","span":{"begin":127,"end":129},"obj":"Chemical"}],"attributes":[{"id":"A1","pred":"chebi_id","subj":"T1","obj":"http://purl.obolibrary.org/obo/CHEBI_59132"},{"id":"A2","pred":"chebi_id","subj":"T2","obj":"http://purl.obolibrary.org/obo/CHEBI_73445"}],"text":"All patients with SRF displayed either macrophage activation syndrome (MAS) or very low human leukocyte antigen D related (HLA-DR) expression accompanied by profound depletion of CD4 lymphocytes, CD19 lymphocytes, and natural killer (NK) cells."}
LitCovid-PD-GO-BP
{"project":"LitCovid-PD-GO-BP","denotations":[{"id":"T3","span":{"begin":39,"end":60},"obj":"http://purl.obolibrary.org/obo/GO_0042116"}],"text":"All patients with SRF displayed either macrophage activation syndrome (MAS) or very low human leukocyte antigen D related (HLA-DR) expression accompanied by profound depletion of CD4 lymphocytes, CD19 lymphocytes, and natural killer (NK) cells."}
LitCovid-sentences
{"project":"LitCovid-sentences","denotations":[{"id":"T7","span":{"begin":0,"end":244},"obj":"Sentence"}],"namespaces":[{"prefix":"_base","uri":"http://pubannotation.org/ontology/tao.owl#"}],"text":"All patients with SRF displayed either macrophage activation syndrome (MAS) or very low human leukocyte antigen D related (HLA-DR) expression accompanied by profound depletion of CD4 lymphocytes, CD19 lymphocytes, and natural killer (NK) cells."}
LitCovid-PMC-OGER-BB
{"project":"LitCovid-PMC-OGER-BB","denotations":[{"id":"T10","span":{"begin":39,"end":49},"obj":"CL:0000235;GO:0042116"},{"id":"T11","span":{"begin":50,"end":60},"obj":"GO:0042116"},{"id":"T12","span":{"begin":88,"end":93},"obj":"SP_6;NCBITaxon:9606"},{"id":"T13","span":{"begin":94,"end":103},"obj":"CL:0000738"},{"id":"T14","span":{"begin":104,"end":111},"obj":"CHEBI:59132;CHEBI:59132"},{"id":"T15","span":{"begin":123,"end":126},"obj":"PR:000029150"},{"id":"T16","span":{"begin":131,"end":141},"obj":"GO:0010467"},{"id":"T17","span":{"begin":179,"end":182},"obj":"PR:000001004"},{"id":"T18","span":{"begin":183,"end":194},"obj":"CL:0000542"},{"id":"T19","span":{"begin":196,"end":200},"obj":"PR:000001002"},{"id":"T20","span":{"begin":201,"end":212},"obj":"CL:0000542"},{"id":"T21","span":{"begin":218,"end":232},"obj":"CL:0000623"},{"id":"T55692","span":{"begin":39,"end":49},"obj":"CL:0000235;GO:0042116"},{"id":"T76896","span":{"begin":50,"end":60},"obj":"GO:0042116"},{"id":"T56154","span":{"begin":88,"end":93},"obj":"SP_6;NCBITaxon:9606"},{"id":"T45303","span":{"begin":94,"end":103},"obj":"CL:0000738"},{"id":"T92944","span":{"begin":104,"end":111},"obj":"CHEBI:59132;CHEBI:59132"},{"id":"T58214","span":{"begin":123,"end":126},"obj":"PR:000029150"},{"id":"T41859","span":{"begin":131,"end":141},"obj":"GO:0010467"},{"id":"T17537","span":{"begin":179,"end":182},"obj":"PR:000001004"},{"id":"T14494","span":{"begin":183,"end":194},"obj":"CL:0000542"},{"id":"T5373","span":{"begin":196,"end":200},"obj":"PR:000001002"},{"id":"T95317","span":{"begin":201,"end":212},"obj":"CL:0000542"},{"id":"T66709","span":{"begin":218,"end":232},"obj":"CL:0000623"}],"text":"All patients with SRF displayed either macrophage activation syndrome (MAS) or very low human leukocyte antigen D related (HLA-DR) expression accompanied by profound depletion of CD4 lymphocytes, CD19 lymphocytes, and natural killer (NK) cells."}
LitCovid-PubTator
{"project":"LitCovid-PubTator","denotations":[{"id":"36","span":{"begin":179,"end":182},"obj":"Gene"},{"id":"37","span":{"begin":196,"end":200},"obj":"Gene"},{"id":"45","span":{"begin":4,"end":12},"obj":"Species"},{"id":"50","span":{"begin":88,"end":93},"obj":"Species"},{"id":"60","span":{"begin":18,"end":21},"obj":"Disease"},{"id":"61","span":{"begin":39,"end":69},"obj":"Disease"}],"attributes":[{"id":"A36","pred":"tao:has_database_id","subj":"36","obj":"Gene:920"},{"id":"A37","pred":"tao:has_database_id","subj":"37","obj":"Gene:930"},{"id":"A45","pred":"tao:has_database_id","subj":"45","obj":"Tax:9606"},{"id":"A50","pred":"tao:has_database_id","subj":"50","obj":"Tax:9606"},{"id":"A61","pred":"tao:has_database_id","subj":"61","obj":"MESH:D055501"}],"namespaces":[{"prefix":"Tax","uri":"https://www.ncbi.nlm.nih.gov/taxonomy/"},{"prefix":"MESH","uri":"https://id.nlm.nih.gov/mesh/"},{"prefix":"Gene","uri":"https://www.ncbi.nlm.nih.gov/gene/"},{"prefix":"CVCL","uri":"https://web.expasy.org/cellosaurus/CVCL_"}],"text":"All patients with SRF displayed either macrophage activation syndrome (MAS) or very low human leukocyte antigen D related (HLA-DR) expression accompanied by profound depletion of CD4 lymphocytes, CD19 lymphocytes, and natural killer (NK) cells."}